论文信息 - Efficacy and Safety of Front-Line Nilotinib Treatment and Discontinuation in Older Patients (≥65 years) with Chronic Myeloid Leukemia in Chronic Phase Who Have Achieved MR4.5: Results from ENESTfreedom - 字舞流文

Efficacy and Safety of Front-Line Nilotinib Treatment and Discontinuation in Older Patients (≥65 years) with Chronic Myeloid Leukemia in Chronic Phase Who Have Achieved MR4.5: Results from ENESTfreedom

J. Radich | F. Giles | G. Saglio | A. Hochhaus | T. Masszi | N. Gattermann | P. Aimone | B. Martino | E. Conneally | A. Hellmann | S. Saussele | D. Ross | J. Stentoft | M. T. G. Casares | Sai Li | Ksenia Titorenko | Philipp le Coutre | J. V. G. Gutiérrez